High Relaxivity Magnetic Resonance Imaging Contrast Agents Part 1: Impact of Single Donor Atom Substitution on Relaxivity of Serum Albumin-Bound Gadolinium Complexes
暂无分享,去创建一个
Peter Caravan | Wei-Chuan Sun | V. Jacques | P. Caravan | H. Schmitt-Willich | Heribert Schmitt-Willich | Stéphane Dumas | Vincent Jacques | J. T. Welch | S. Dumas | Jeffrey S Troughton | Wei-Chuan Sun | Jaclyn M Chasse | Joel T Welch | J. Troughton | Jaclyn M. Chasse
[1] Enzo Terreno,et al. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. , 2009, Accounts of chemical research.
[2] A. Trzeciak,et al. A Simple and Effective Chemical Phosphorylation Procedure for Biomolecules , 1987 .
[3] Paul Jurek,et al. Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH. , 2007, Inorganic chemistry.
[4] M. Port,et al. Correlation of Water Exchange Rate with Isomeric Composition in Diastereoisomeric Gadolinium Complexes of Tetra(carboxyethyl)dota and Related Macrocyclic Ligands , 2000 .
[5] Joop A. Peters,et al. Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate. , 2005, Chemistry.
[6] Seymour H. Koenig,et al. Field-cycling relaxometry of protein solutions and tissue: Implications for MRI , 1990 .
[7] Thomas J Meade,et al. Bioresponsive, cell-penetrating, and multimeric MR contrast agents. , 2009, Accounts of chemical research.
[8] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[9] M. Botta,et al. Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI , 2000, JBIC Journal of Biological Inorganic Chemistry.
[10] A. Sautter,et al. Photoinduced Electron and Energy Transfer Processes in a Bichromophoric Pyrene-Perylene Bisimide System , 2004 .
[11] M. Caruthers,et al. In situ activation of bis-dialkylaminophosphines--a new method for synthesizing deoxyoligonucleotides on polymer supports. , 1984, Nucleic acids research.
[12] M. Port,et al. A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles. , 2006, Journal of the American Chemical Society.
[13] Peter Caravan,et al. Determination of the hydration number of gadolinium(III) complexes by high-field pulsed 17O ENDOR spectroscopy. , 2006, Chemphyschem : a European journal of chemical physics and physical chemistry.
[14] Peter Caravan,et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. , 2002, Journal of the American Chemical Society.
[15] S. Bott,et al. Synthesis, relaxometric and photophysical properties of a new pH-responsive MRI contrast agent: the effect of other ligating groups on dissociation of a p-nitrophenolic pendant arm. , 2004, Journal of the American Chemical Society.
[16] H. Thomsen,et al. High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent , 2008, Investigative radiology.
[17] J. Kowalewski,et al. Nuclear spin relaxation in paramagnetic systems (S>/=1) under fast rotation conditions. , 2003, Journal of magnetic resonance.
[18] I. Solomon. Relaxation Processes in a System of Two Spins , 1955 .
[19] C. Eguchi,et al. The Novel Synthesis of L -Hydroxyproline from D -Glutamic Acid , 1974 .
[20] R. Lauffer,et al. Targeted relaxation enhancement agents for MRI , 1991, Magnetic resonance in medicine.
[21] Claudio Luchinat,et al. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. , 2007, Inorganic chemistry.
[22] A. Seelig,et al. High Relaxivity for Monomeric Gd(DOTA)‐Based MRI Contrast Agents, Thanks to Micellar Self‐Organization , 1999 .
[23] J. Serfaty,et al. In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms , 2010, Investigative radiology.
[24] Peter Caravan,et al. Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. , 2008, Chemistry.
[25] E. Küng,et al. Bis(allyloxy)(diisopropylamino)phosphine as a new phosphinylation reagent for the phosphorylation of hydroxy functions , 1989 .
[26] L. Helm,et al. T1e in four Gd3+ chelates: LODEPR measurements and models for electron spin relaxation , 2002 .
[27] Alain Borel,et al. How does internal motion influence the relaxation of the water protons in Ln(III)DOTA-like complexes? , 2002, Journal of the American Chemical Society.
[28] É. Tóth,et al. The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent. , 2002, Chemistry.
[29] Peter Caravan,et al. Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent. , 2004, Inorganic chemistry.
[30] Paul Bernard,et al. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents. , 2002, Journal of medicinal chemistry.
[31] Peter Caravan,et al. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. , 2009, Contrast media & molecular imaging.
[32] Peter Caravan,et al. Pulsed ENDOR Study of Water Coordination to Gd3+ Complexes in Orientationally Disordered Systems , 2004 .
[33] G. Lipari. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules , 1982 .
[34] A. Sherry,et al. The Effect of the Amide Substituent on the Biodistribution and Tolerance of Lanthanide(III) DOTA-Tetraamide Derivatives , 2008, Investigative radiology.
[35] R. Ranganathan,et al. New multimeric magnetic resonance imaging agents. , 1998, Investigative radiology.
[36] Peter Caravan,et al. Species Dependence on Plasma Protein Binding and Relaxivity of the Gadolinium-Based MRI Contrast Agent MS-325 , 2006, Investigative radiology.
[37] P. Caravan,et al. A High Relaxivity Magnetic Resonance Imaging Contrast Agent Targeted to Serum Albumin , 2008 .
[38] Peter Caravan,et al. Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide. , 2007, Inorganic chemistry.
[39] L. Helm,et al. Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1 , 1996 .
[40] S. Morcos,et al. Nephrogenic Gadolinium Biodistribution and Skin Cellularity Following a Single Injection of Omniscan in the Rat , 2010, Investigative radiology.
[41] K. Binnemans,et al. Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. , 2007, Dalton transactions.
[42] Nicolaas Bloembergen,et al. Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation , 1961 .
[43] X. Li,et al. The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities. , 2001, Inorganic chemistry.
[44] M. Botta,et al. Structure and relaxivity of macrocyclic gadolinium complexes incorporating pyridyl and 4-morpholinopyridyl substituents , 1999 .
[45] U. Schmidt,et al. Enantioselective Syntheses of (R)- and (S)-Hexahydropyridazine-3-carboxylic Acid Derivatives , 1996 .
[46] Peter Caravan,et al. Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.
[47] S. Rast,et al. A general approach to the electronic spin relaxation of Gd(III) complexes in solutions. Monte Carlo simulations beyond the Redfield limit , 2001 .
[48] V. Runge. Gadolinium and nephrogenic systemic fibrosis. , 2009, AJR. American journal of roentgenology.
[49] A. Sherry,et al. Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes. , 2003, Angewandte Chemie.
[50] Peter Caravan,et al. High-Relaxivity Magnetic Resonance Imaging Contrast Agents Part 2: Optimization of Inner- and Second-Sphere Relaxivity , 2010, Investigative radiology.
[51] Sophie Laurent,et al. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. , 2006, Contrast media & molecular imaging.
[52] A. Szabó,et al. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .
[53] Oleg G. Poluektov,et al. High-field pulsed EPR and ENDOR of Gd3+ complexes in glassy solutions , 2005 .
[54] M. Botta,et al. Towards the rational design of MRI contrast agents: a practical approach to the synthesis of gadolinium complexes that exhibit optimal water exchange. , 2005, Dalton transactions.
[55] Peter Caravan,et al. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.
[56] S Aime,et al. pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. , 2001, Journal of the American Chemical Society.
[57] L. Helm,et al. Inorganic and bioinorganic solvent exchange mechanisms. , 2005, Chemical reviews.
[58] Peter Caravan,et al. The gadolinium(III)-water hydrogen distance in MRI contrast agents. , 2003, Inorganic chemistry.